华大基因：生华投资减持125.07万股股份

Core Viewpoint - Shenzhen Shenghua Investment Enterprise (Limited Partnership), a shareholder holding more than 5% of BGI Genomics (300676.SZ), reduced its stake in the company by selling 1,250,700 shares, representing 0.2990% of the total share capital, between September 4 and September 8, 2025 [1] Shareholding Changes - Following the reduction, Shenghua Investment's shareholding percentage decreased from 8.2403% to 7.9413% [1] - The reduction in shareholding includes both the sale of shares and passive dilution due to the company's restricted stock incentive plan [1] Previous Reductions - From May 26, 2021, to September 10, 2021, Shenghua Investment had already reduced its holdings by 261,800 shares through centralized bidding and block trading [1]